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Mutations and Homologous Recombination
Induced in Mammalian Cells by Metabolites
of Benzo[aJpyrene and 1-Nitropyrene
by Veronica M. Maher,* Joe Dale Patton,* Jia-Ling Yang,*
Yenyun Wang,* Li L. Yang,* Ann E. Aust,* Nitai
Bhattacharyya,* and J. Justin McCormick*
Metabolites of two structurally related chemical carcinogens, benzo[a]pyrene and 1-nitropyrene, were
compared for their ability to cause cytotoxicity and induce mutations in normally repairing or nucleotide
excision repair-deficient diploid human fibroblasts; for their ability to induce mutations in a defined gene
sequence, supF, when a plasmid containing adducts formed by these carcinogens replicates in human 293
cells; and fortheirability to induce homologous recombination between duplicated genes in mouse L cells.
Both ofthe metabolites tested, i.e., (± )-73,8a-dihydroxy-9a,1Oa, epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene
(BPDE) and 1-nitrosopyrene (1-NOP), form adducts on guanine. BPDE bindsprincipally attheN2position
of guanine; 1-NOP binds to guanine at the C8 position. Results of the studies in diploid human cells
indicated that when compared on the basis of equal numbers of DNA adducts, BPDE is more effective
than 1-NOP in inducing mutations in DNA repair-proficient cells, but when compared in repair-deficient
xeroderma pigmentosum human cells that do not remove such adducts from their DNA, the frequency of
mutants induced per adduct is equal. These results suggest that during the time available for repair of
potentially mutagenic lesions, repair-proficient human cells excise 1-NOP adducts more rapidly than they
excise BPDE adducts. Molecular analysis. of the specific kinds of mutations induced when a plasmid
containing BPDE residues was allowed to replicate in human cells showed that BPDE induces mainly
base substitution mutations, predominantly G:C to T:A transversions. Preliminary results with 1-NOP-
treated plasmids inthatsystem indicatethat 1-NOPis notasmutagenic asBPDE whenthetwocarcinogens
are compared on the basis of equal initial numbers of adducts per plasmid. Just as was the case for
mutation induction in the genome of diploid human fibroblasts discussed above, the difference in muta-
genicity peradduct mayreflect adifference in excisionrepairrate bythe humancell line293. Thisquestion
is under investigation. In addition, preliminary results ofastudy comparing 1-NOP with BPDE for ability
to induce homologous recombination in mouse L cells indicate that BPDE is more effective than 1-NOP.
Introduction
As a basis for risk assessment, it is important to
determine the biological effects of exposure of animals
and human beings to environmental carcinogenic and
mutagenic agents. Our laboratory has been investigat-
ing the biological effects of such agents in mammalian
cells in culture in an effort to understand the mecha-
nisms ofmutagenesis and carcinogenesis at the cellular
and molecular level. The majority of our studies have
been carried out with diploid human fibroblasts, but
more recently we have also employed an established
human cell line transformed by DNA from adenovirus
and a thymidine kinase-deficient mouse L cell line.
As part of studies of the mechanisms of carcinogen-
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esis, we and our co-workers have investigated the cyto-
toxicity, mutagenicity, and transforming activity of a
number ofchemical carcinogens and radiation in diploid
human fibroblasts that differ in their ability to excise
DNA lesions caused by such agents. For example, we
have asked whether cell killing and/or mutation induc-
tion is correlated with the initial number of DNA
adducts or the number of adducts remaining at a par-
ticular time posttreatment; whether potentially muta-
genic lesions are converted into mutations during exci-
sion repair, the role of semiconservative DNA repli-
cation in mutation induction; whether particular lesions
or adducts are intrinsically more mutagenic or more
cytotoxic than others; and whether genetic changes
resulting from unrepaired DNA lesions are causally
involved in the process of neoplastic transformation.
To address these questions, we developed quantita-
tive assays formeasuringthe cytotoxic, mutagenic, and
transformingeffect ofcarcinogens indiploid humanskinMAHER ET AL.
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FIGURE 1. Proposed pathwayforcellularactivationof1-NP. Metab-
olism proceeds via reduction of the parent compound to 1-NOP,
followed byreduction to the corresponding hydroxylamine and the
formnation of a nitrenium intermediate which reacts with DNA to
form a covalently bound adduct, i.e., N-(deoxyguanosin-8-yl)-1-
aminopyrene. After Patton et al. (11) with permission.
fibroblasts derived fromneonatalforeskin or skinbiopsy
material (1-4). Human cells grow well in culture and
form colonies at low cell density with an efficiency of40
to 80%. They can be treated with direct-acting muta-
gens and the cytotoxic effect quantitated from the
decrease in their cloning ability. Compounds requiring
metabolic activation can also be used if the cells are
provided with a source of activation, such as metabo-
lizing human feeder cells (5,6). The dose-dependent
induction of mutations by carcinogens can be quanti-
tated bydeterminingthe frequency ofcells able to grow
inthe presence of6-thioguanine (TG) as aresultofmuta-
tions that inactivate hypoxanthine(guanine)phosphori-
bosyltransferase (1-3) or in the presence of diphtheria
toxin (DT) as a result ofinactivation ofits receptor site
on the elongation factor 2 (7). The frequency of trans-
formation ofnormaldiploidhumancells canbemeasured
by determining the frequency of cells able to exhibit
anchorage-independent growth, i.e., colony formation
in semisolid medium containing 0.33% agar (3,4). Such
anchorage-independent diploid human cells still possess
a finite life-span in culture and are not capable of pro-
ducing malignant tumors, but anchorage independence
is a phenotype highly characteristic of tumor-derived
cells.
For studies on the effect of DNA repair on these
processes, we have made use of nucleotide excision re-
pair-deficient fibroblasts derived from xeroderma pig-
mentosum (XP) patients (2,3). In particular, we have
studied XP12BE cells, which we showed are unable to
excise UV radiation-induced photoproducts from DNA
or multiringed residues formed in DNA by reactive de-
rivatives of polycyclic aromatic carcinogens, such as 2-
acetylaminofluorene (8), benzo[a]pyrene (9,10), and 1-
nitropyrene (11,12). We have recently extended our
studies of the biological effects of carcinogens and mu-
tagens to determine, at the sequence level, the number
and kinds ofmutations induced in a defined gene, supF,
when carcinogen-treated plasmid is replicated in an es-
tablished human cell line (13). We have also begun to
assay the ability of such agents to induce homologous
recombination between duplicated genes in the genome
of mouse L cells (14). In this report we summarize the
data we have obtained using metabolites of two struc-
turally related polycyclic aromatic carcinogens, benzo-
[a]pyrene and 1-nitropyrene. The metabolites studied
are (-+)7-3,8ax-dihydroxy-9a,10a,epoxy-7,8,9,10-tetra-
hydrobenzo[a]pyrene (BPDE) and 1-nitrosopyrene
(1-NOP), the partially reduced metabolite of 1-nitropy-
rene. Both metabolites are carcinogenic and both bind
covalently to guanine. 1-NOP forms only a single major
DNA adduct at the C8 position (Fig. 1) (15); BPDE
forms its principal adduct at the N2 position ofguanine
(16).
Comparison of the Cytotoxic and
Mutagenic Effects of BPDE and
1-NOP in Diploid Human Cells
Cytotoxicity and Mutagenicity of BPDE in
Diploid Human Fibroblasts
Normally repairing foreskin-derived diploid human
fibroblasts and nucleotide excision repair-deficient cells
derived from XP patient XP12BE were compared for
their sensitivity to the cytotoxic and mutagenic effects
of BPDE as a function of the applied concentration.
Normal cells in exponential growth were trypsinized,
plated at densities of3.3 to 8 x 103 cells/cm2 in culture
medium containing serum, and allowed to attach for 16
hr. The medium was exchanged for serum-free medium
and the carcinogen, freshly dissolved in anhydrous
dimethylsulfoxide or acetone, was introduced into the
dishes by micropipette as described previously (10). In
the case of the XP cells, the same conditions were
employed for most ofthe experiments, but in one, the
cells were treated at confluence, as described (10). The
number of target cells was adjusted so as to have at
least 106 surviving cells for each determination. Cyto-
toxicity was determined by immediately plating cells at
low (cloning) densities, i.e., 50 to 500 cells per dish
depending on the expected numberofcolonies. A series
ofdishes containing cells plated at various low densities
was employed so as to have six or more dishes contain-
ing -40 colonies each. Mutagenicity was assayed by
keeping treated and untreated populations in exponen-
tialgrowthduringa 7to 10dayexpressionperiodbefore
selecting 1 to 2 x 106 cells per determination for the
frequency of cells resistant to 6-thioguanine (1,7,11).
The results are shown in Figure 2. The repair-defi-
cient XP cells were significantly more sensitivethanthe
normal cells to the cytotoxic and the mutagenic effects
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FIGURE 2. Cytotoxic and mutagenic effect of BPDE in normal (0)
or XP (A) human fibroblasts as a function of concentration. The
cells were treated at a density of 0.33-0.8 x 104 cells/cm2. The
background mutant frequencies per 106 clonable cells ranged from
O to 22 for XP cells and from 5 to 19 for normal cells. The muta-
genicity data have been corrected for these backgrounds. The
straight line portions ofthe curves were calculated by the method
ofleast squares.
of BPDE. A concentration of0.02 ,uM was sufficient to
lower their survival to 37% of the untreated control;
0.16 ,uM was required for the repair-proficient normal
cells. Those same concentrations increased the fre-
quency of mutations to 75 x 10-6 and 160 x 10-6,
respectively.
Evidence thattheabnormalsensitivityoftheXPcells
to BPDE reflected an inability of the cells to remove
BPDE adducts from their DNA was published previ-
ously (9,10). Such a conclusion can be drawn from the
data in Figure 3, showing that XP12BE cells initially
possessingsix BPDE residues per 106 DNAnucleotides
exhibit a survival of 5%, but normally repairing cells
with the same initial number of adducts exhibit a sur-
vival of 50%. It takes eight initial residues per 106
nucleotides to lower the survival ofthe normal cells to
37%, but only two per 106 nucleotides for the XP cells,
suggestingthat the repair-proficient cells remove many
of the potentially cytotoxic residues from DNA before
these can exert their killing effect.
Cytotoxicity and Mutagenicity of 1-NOP in
Diploid Human Fibroblasts
A similar comparative study was carried out by Pat-
ton et al. (11,12) using 1-nitropyrene and 1-nitrosopy-
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FIGURE 3. Comparison of the cytotoxic effects of BPDE in nornal
(e) or repair-deficient diploid human cells (A) as a function ofthe
initial number ofresidues bound to cellular DNA at the end ofthe
exposure period. The cells were treated for 1 hrat confluence with
tritiated BPDE (XP, 0.025 and 0.05 IiM; NF, 0.15, 0.2, and 0.3
FM) and then immediately harvested and assayed for survival and
extent ofbinding to cellular DNA. Lines were determined by the
method of least squares. The majority of these data were taken
from (9).
rene. The results with 1-NOP are shown in Figure 4.
Again, the repair-deficient XP cells proved significantly
more sensitive than normal cells to the cytotoxic and
mutagenic effects ofthis multiringed carcinogen. Acon-
centration of 0.16 ,uM reduced their survival to 37% of
the control. For the repair-proficient normal cells 0.6
FM was required. Those same concentrations increased
the frequency of mutations to 150 x 10-6 and 70 x
10-6, respectively.
Evidence thatthe abnormalsensitivityofthe XPcells
to 1-NOP reflected their inability to remove adducts
from their DNA can be seen in Figure 5. Given approx-
imately the same concentration of 1-NOP, i.e., 0.7 and
0.73 ,uM, normal and XP cells exhibited the same initial
number ofDNA adducts per 106 nucleotides (i.e., -22).
But XP cells exhibited a survival of 0.2% and normal
cells showed 25% survival. It takes 25 initial 1-NOP
residues to lower the survival or the normal cells to
37%, but only four per 106 nucleotides for the XP cells.
In contrast to what we found with BPDE, at a 37%
survival dose, the normal cells have a frequency of
induced mutations twofold lowerthanthe XP cells, sug-
gestingthatthe normal cellswere abletoremove poten-
tiallymutagenic 1-NOP adducts fromtheir DNAbefore
these adducts could exert their mutagenic effect. This
difference inthe mutation results obtained withthe two
compounds suggests that normal human cells remove
1-NOP-induced residues from their DNA faster than
they remove BPDE adducts.
Because of these possible differences in rate of exci-
sionrepairofadducts, itisnotasinformativetocompare
the mutagenic effect of two agents on the basis of the
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FIGURE 4. Cytotoxic and mutagenic effect of 1-NOP in normal (0)
or XP (A) human fibroblasts as a function of concentration. The
cells were treated at a density of0.33-1 x 104 cells per cm2. The
background mutant frequencies per 106 clonable cells ranged from
0 to 13 for XP cells and from 0 to 8 for normal cells. The muta-
genicity data have been corrected for these backgrounds. The
straight line portions ofthe curves were calculated by the method
of least squares. After Patton et al. (11) with permission.
initialnumberofDNA adducts formed. However, ifone
isworkingwith a cellline thatdoes not remove adducts,
e.g., XP12BE cells, thenthenumberofadductsremain-
inginthe DNAatthetimepotentiallymutageniclesions
are converted into mutations ("fixed") is the same as
the initialnumberofadducts. Therefore, one canvalidly
compare the frequency ofmutants induced in such cells
as afunction ofinitial adducts. Acomparison ofthe data
in Figures 2 through 5 shows that in XP12BE cells, two
BPDE adducts per 106 nucleotides induces a mutant
frequency of 75 x 106, whereas four 1-NOP adducts
per 106 nucleotides induces -150 x 10'. Thus, the
mutagenic effectiveness of the agents in these cells
appears to be equal.
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FIGURE 5. Comparison ofthe cytotoxic effects of 1-NP (open sym-
bols) and 1-NOP (closed symbols) in NF (e, 0) and XP (A, A) cells
as a function ofthe number ofresidues bound to cellular DNA at
the end ofthe exposure period (1-NP, 10 hr; 1-NOP, 1 hr). Expo-
nentially growing cells at a density of 104 cells/cm2 were exposed
to radioactive-labeled compound (1-NP; XP, 14 or 20 ,uM; NF 50
and 80 ,M; 1-NOP; XP 0.36 and 0.73 ,uM; NF, 0.7, 1.0 and 2.1
,M). The cellswereharvested and assayed forsurvival and extent
ofbinding to cellular DNA. Lines were determined bythe method
ofleast squares. After Patton et al. (11) with permission.
Comparison of the Mutagenicity of
BPDE and 1-NOP Adducts When a
Plasmid Replicates in a Human Cell
Line
Number and Kinds of Mutations Induced
by BPDE
Recently, Yang et al. (13), using a shuttle vector,
pZ189, showed that when the plasmid carrying BPDE
adducts replicated in human 293 cells, the mutations
induced in the target gene, supF, coding for a tyrosine
tRNA, were predominantly single base substitutions.
The frequency of mutants induced in this system as a
function of BPDE adducts is shown in Figure 6. DNA
sequence analysis of 86 independent mutants derived
with BPDE-treated plasmids showed that the majority
(60/86) exhibited base substitutions, with the majority
(75%) being G:C to T:A transversions (13). Two very
prominent hot spots were found. Molecular analysis of
30 spontaneous mutantsshowed thatthemajority (70%)
involved deletions, insertions, or altered gel mobility.
Preliminary Studies with 1-NOP
These same investigators are currently undertaking
a similar study using the pZ189 plasmid treated with
tritiated 1-NOP in the presence of ascorbic acid. Pre-
liminary results suggest that when compared on the
basis of equal numbers of adducts per plasmid, 1-NOP
is not as effective as BPDE in inducing mutations when
36
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FIGURE 6. (A) BPDE residues per pZ189 plasmid as a function ofapplied concentration; (e) and (A) denote two separate binding experiments.
(B) Frequency of transformation of the E. coli host to ampicillin resistance by BPDE-modified plasmid. The error bars indicate the SEM
offive determinations. (C) Frequency ofsupF mutants induced when the BPDE-treated plasmid replicated in human cells 293 cells, plotted
as a function ofthe number of BPDE residues per plasmid. The error bars refer to SEM ofthe mutant frequencies from a series ofhuman
cell transfection experiments made with each set of treated plasmid. Taken from (13) with permission.
the plasmid replicates in human cells. Whether this dif-
ference reflects the intrinsic difference in the nature of
the guanine adducts formed or reflects a difference in
the rate ofremoval ofthe adducts from the plasmid by
the human 293 cell line before they can cause mutations
is currently under investigation in our laboratory.
Comparison of the Recombinagenic
Effect of BPDE and 1-NOP in Mouse
L Cells
Frequency of Recombination Induced by
BPDE
To try to understand the mechanisms of chemical and
physical carcinogenesis, we have investigated whether
carcinogens can induce homologous recombination
between genes located within the mammalian cell genome
and characterized the kinds of recombination events
induced (14). A comparison ofthe various agents for their
ability to induce recombination as a function oftheir cyto-
toxic effect or the number of DNA lesions they induce
could shed light on the mechanisms involved. The system
employed was designed by Liskay et al. (17). It involves
a thymidine kinase (tk)-deficient mouse L cell line, des-
ignated 333M, which contains a single, stably integrated
plasmid carrying duplicated copies ofthe Herpes simplex
virus tk gene (Htk), each inactivated by an eight bp Xho
I linker mutation at a unique site. After exposure to the
mutagenic agents, the tk- target cells are selected for
expression of a functional Htk enzyme, which requires a
productive recombinational event between the two non-
functional genes. To date, the mutagens we have tested
in this system include ultraviolet radiation, N-methyl-N'-
nitro-N-nitrosoguanidine, mitomycin C, and BPDE (14).
For such studies, sufficient target cells are used so as
to have at least 2 x 106 surviving cells to be assayed for
recombination frequency by selection in medium contain-
ing cytidine, hypoxanthine, aminopterin, and thymidine
(CHAT medium) (14). The results obtained with BPDE
are shown in Figure 7. The doses required to reduce the
cell survival to between 90% and 10% are very similar to
those for normal diploid human fibroblasts (Fig. 2). There
was a dose-dependent increase in the frequency of tk+
recombinants. The highest doses (2.5 ,uM) increased the
frequency from a background frequency of 19 x 10-6 to
60 x 10-6 , giving an induced frequency of41 x 10-6. A
37% survival dose (0.18 ,uM) gave an induced frequency
of 25 x 10-6. Binding data with radiolabeled BPDE
showed that at 37% survival the number of adducts is 9
per 106 DNA nucleotides (data not shown).
Frequency of Recombination Induced by
1-NOP
Results ofpreliminary studies with this system using
1-NOP showed that the concentration needed to reduce
the survival of mouse L cells to 37% was 0.6 ,uM (data
not shown). This quantity is similar to that needed for
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FIGURE 7. Cell killing and induction ofrecombination as a function
of the concentration of BPDE. The cells were plated at 104 cells/
cm2 and treated with BPDE for 1 hr. Immediately following treat-
ment, one set of cells were plated at cloning densities to assay
survival. The rest were allowed -20 hr before being selected in
situforresistance to CHATmedium(tk+ recombinants). Theback-
ground frequencies in the three experiments ranged from 16.3 x
10-6 to 19.5 x 10-6. These have been subtracted to give induced
frequences of recombinants. Taken from (14) with permission.
normal diploid human cells, i.e., 0.75 ,uM (Fig. 4). The
frequency of tk+ recombinants induced by 1-NOP at
that concentration was 32 x 10-4 (data not shown). In
human fibroblasts, an applied concentration of 0.7 j,M
1-NOP induced 23 adducts per 106 nucleotides (Fig. 5).
Binding data with radiolabeled 1-NOP showed that at
37% survival (0.6 1xM) the number of adducts is 34 per
106 DNA nucleotides. Therefore, the recombinagenic
activity of1-NOP per adduct in mouse L cells is at least
twofold lower than that of BPDE. However, before
drawing conclusions about the ability of DNA adducts
to induce such biological effects, it will be necessary to
determine ifmouse L cells canexcise these adductsfrom
their DNA and whether they remove 1-NOP adducts
faster than they excise BPDE residues. Such compar-
ative studies are presently underway in our laboratory.
Kinds of Recombination Events Induced
by These Agents
The plasmid used by Liskay et al. (17) to transfect
mouse L cells to obtain the 333M target cells was
designed to facilitate analysis of the kinds of recombi-
nation events which take place. In addition to duplicate
Htk genes, eachwith aneightbpXho I linkerframeshift
mutation in a unique location, the plasmid contains the
neo gene coding for Geneticin resistance located
between the two Htk genes to facilitate assaying the
tk+ recombinants for the retention or loss ofthe inter-
vening DNA sequence. If the recombination event
involves asinglereciprocal exchangewithinachromatid
orasingleunequalexchangebetweensisterchromatids,
only a single wild-type copy ofthe Htk cell gene will be
present and the sequence containing the neo gene will
be lost. In contrast, ifthe recombination event consists
of a nonreciprocal transfer of wild-type information
(gene conversion), the Htk gene duplication, including
the neo gene, will be retained in the recombinant, but
oneHtkgenewillbewild-type. Therefore, simplyassay-
ingtk+recombinants forresistance to Geneticin can dis-
tinguish which type of event occurred. Southern blot
analysis ofDNA from such recombinants can readily be
used to confirm these results, since each Htk gene was
inserted at a unique restriction site locus in the original
plasmid (17). Wang et al. (14) have carried out such a
study and found that 85 to 90% of the BPDE-induced
recombinants involved gene conversion. Thus, BPDE
raised the frequency of both kinds of recombinant
events in the same proportions as they occur sponta-
neously (17). Investigation of the kinds of events
induced by 1-NOP has not yet been carried out.
Conclusion
Our studies with BPDE and 1-NOP as model envi-
ronmental carcinogens in excision repair-proficient and
repair-deficient human fibroblasts indicate that when
the agents are compared on the basis of applied con-
centration, BPDE is more active than 1-NOP. When
the mutagenicity of two agents is compared at doses
causing equal cytotoxicity ("mutagenic efficiency") in
the repair-proficient cells, BPDE is more mutagenic
than 1-NOP. This is also true when the two are com-
pared for the frequency of mutants induced in normal
human cells as a function ofthe initial number ofDNA
adducts formed ("mutagenic effectiveness"). However,
in XP cells that areunable toremove BPDE- or 1-NOP-
induced adducts, the mutagenic effectiveness ofthe two
carcinogens is equal. This suggests that followingexpo-
sure to the agents, the repair-proficient cells remove a
greater fraction of the potentially mutagenic 1-NOP-
induced adducts than BPDE-induced adducts before
these can be converted into mutations. This prediction
would explain why plasmids containing BPDE-induced
adducts showed a higher frequency ofmutants induced
in the target gene (supF) than did plasmids carrying 1-
NOP adducts.
The ongoing study comparing BPDE and 1-NOP for
their recombinagenic ability in mouse L cells suggests
that BPDE is twice as effective as 1-NOP. However,
additional studies are required before one candrawthis
conclusion since the mouse L cells also may be capable
ofremoving1-NOP-inducedmutantsfasterthanBPDE-
induced adducts. Nevertheless, the data from each of
the studies described here demonstrate the importance
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of determining the biologic effect of given agents not
only on the basis ofapplied concentrations, but also as
a function of DNA damage, both initial and persistent.
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